INTERCEPT PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
22 Jun 2021	Form 3: Saik Andrew, EVP & Chief Financial Officer No securities owned
15 Jun 2021	Form 3: Berrey M Michelle, President, R&D and CMO No securities owned
05 Apr 2021	Form 3: Venezia Rocco, Chief Accounting Officer Holds 14,318 shares of Common Stock
05 Apr 2021	Form 3: Rosa-bjorkeson Dagmar, Director No securities owned
17 Feb 2021	Form 3: DeFrancesco Lisa, SVP, IR & Corp. Affairs Holds 11,592 shares of Common Stock
17 Feb 2021	Form 3: Richardson Linda M, EVP & Chief Commercial Officer Holds 21,335 shares of Common Stock
01 Feb 2021	Form 3: Freedberg Jared, General Counsel and Secretary No securities owned
11 Jan 2021	Form 3: Ball Bryan, Chief Quality Officer No securities owned
05 Dec 2019	Form 3: Campagna Jason, Chief Medical Officer Holds 7,678 shares of Common Stock
14 Dec 2018	Form 3: Cawkwell Gail, SVP, Med Affairs, Safety & PV Holds 15,025 shares of Common Stock
25 Apr 2018	Form 3: Miller-Rich Nancy, Director No securities owned
15 Feb 2018	Form 3: Sullivan Ryan T, General Counsel No securities owned
11 Dec 2017	Form 3: Weyer Christian, EVP Research and Development No securities owned
12 May 2017	Form 3: Kim Richard J, SVP, Commercial US Holds 2,026 shares of Common Stock
10 May 2017	Form 3: Ford David A, Chief Human Resources Officer No securities owned
27 Feb 2017	Form 3: Durso Jerome Benedict, Chief Operating Officer No securities owned
21 Jul 2016	Form 3: Gottesdiener Keith Michael, Director No securities owned
21 Jul 2016	Form 3: Bradbury Daniel, Director No securities owned
06 Jul 2016	Form 3: Kapadia Sandip, Chief Financial Officer No securities owned
27 Nov 2015	Form 3: Santini Gino, Director No securities owned

Comments